TNF and ankylosing spondylitis: In summary, our results represent the first research study investigating the significance of the rs1052248 NCR3, rs396991 FCγR3A, and rs763361 DNAM-1 polymorphisms in the pathogenesis, progression, and response to therapy with TNF inhibitors in Polish patients with rheumatoid arthritis and ankylosing spondylitis.